Literature DB >> 18033969

Tonsillectomy in children: indications, diagnosis and complications.

S L Smith1, K D Pereira.   

Abstract

The indications for pediatric adenotonsillectomy have changed over time from chronic pharyngitis to sleep-disordered breathing. It is important to thoroughly evaluate children for symptoms related to these problems. Symptoms of sleep-disordered breathing range from snoring to obstructive events. Diagnosis is made from accurate history taking, physical examination, and polysomnography. Although surgical treatment has been shown to improve the quality of life in these children, it is not without risks, including bleeding, velopharyngeal insufficiency or postobstructive pulmonary edema. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18033969     DOI: 10.1159/000108364

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  4 in total

1.  A descriptive feasibility study to evaluate scheduled oral analgesic dosing at home for the management of postoperative pain in preschool children following tonsillectomy.

Authors:  Kimberly A Sutters; Danielle Holdridge-Zeuner; Steven Waite; Steven M Paul; Marilyn C Savedra; Brent Lanier; Karla Mahoney; Christine Miaskowski
Journal:  Pain Med       Date:  2012-02-07       Impact factor: 3.750

Review 2.  Indications for tonsillectomy stratified by the level of evidence.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

Review 3.  Pulmonary edema post-adenotonsillectomy in children.

Authors:  Elaf Ahmed; Nasser K Almutairi
Journal:  Saudi Med J       Date:  2018-06       Impact factor: 1.484

4.  Previous tonsillectomy modifies odds of tonsil and base of tongue cancer.

Authors:  Jose P Zevallos; Angela L Mazul; Nidia Rodriguez; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; D Neil Hayes; Andrew F Olshan
Journal:  Br J Cancer       Date:  2016-03-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.